N
Nadia Wohlwend
Publications - 15
Citations - 206
Nadia Wohlwend is an academic researcher. The author has contributed to research in topics: Population & Internal medicine. The author has an hindex of 6, co-authored 13 publications receiving 121 citations.
Papers
More filters
Journal ArticleDOI
Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study.
Rita Christiane Baron,Lorenz Risch,Myriam Weber,Sarah Thiel,Kirsten Grossmann,Nadia Wohlwend,Thomas Lung,Dorothea Hillmann,Michael Ritzler,Susanna Bigler,Konrad Egli,Francesca Ferrara,Thomas Bodmer,Mauro Imperiali,Sonja Heer,Harald Renz,Lukas Flatz,Philipp Kohler,Pietro Vernazza,Christian R Kahlert,Christian R Kahlert,Matthias Paprotny,Martin Risch +22 more
TL;DR: RT-PCR at initial presentation in patients with suspected COVID-19 can miss infected patients and antibody titers of SARS-CoV-2 assays are linked to the number of disease symptoms and the duration of disease.
Journal ArticleDOI
Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study
Anna Schaffner,Lorenz Risch,Stefanie Aeschbacher,Corina Risch,Myriam Weber,Sarah Thiel,Katharina Jüngert,Michael Pichler,Kirsten Grossmann,Nadia Wohlwend,Thomas Lung,Dorothea Hillmann,Susanna Bigler,Thomas Bodmer,Mauro Imperiali,Harald Renz,Philipp Kohler,Pietro Vernazza,Christian R Kahlert,Christian R Kahlert,Raphael Twerenbold,Matthias Paprotny,David Conen,Martin Risch +23 more
TL;DR: In conclusion, a quantitative SARS-CoV-2 S1-RBD Ig assay offers favorable and sustained assay characteristics allowing the determination of quantitative associations between clinical characteristics (e.g., disease severity, smoking or fever) and antibody levels.
Journal ArticleDOI
Quantification of the spread of SARS-CoV-2 variant B.1.1.7 in Switzerland.
Chaoran Chen,Sarah Nadeau,Ivan Topolsky,Marc Manceau,Jana S. Huisman,Kim Philipp Jablonski,Lara Fuhrmann,David Dreifuss,Katharina Jahn,Christiane Beckmann,Maurice Redondo,Christoph Noppen,Lorenz Risch,Martin Risch,Nadia Wohlwend,Sinem Kas,Thomas Bodmer,Tim Roloff,Madlen Stange,Adrian Egli,Isabella Eckerle,Laurent Kaiser,Rebecca Denes,Mirjam Feldkamp,Ina Nissen,Natascha Santacroce,Elodie Burcklen,Catharine Aquino,Andreia Cabral de Gouvea,Maria Domenica Moccia,Simon Grüter,Timothy Sykes,Lennart Opitz,Griffin White,Laura Neff,Doris Popovic,Andrea Patrignani,Jay Tracy,Ralph Schlapbach,Emmanouil T. Dermitzakis,Keith Harshman,Ioannis Xenarios,Henri Pegeot,Lorenzo Cerutti,Deborah Penet,Anthony Blin,Melyssa Elies,Christian L. Althaus,Christian Beisel,Niko Beerenwinkel,Martin Ackermann,Tanja Stadler +51 more
TL;DR: This study estimates the transmission fitness advantage and the effective reproductive number of B.1.1-CoV-2 variant of Concern in Switzerland and quantifies the variant’s transmission Fitness advantage on a national and a regional scale.
Journal ArticleDOI
Evaluation of a multiplex real-time PCR assay for detecting major bacterial enteric pathogens in fecal specimens: intestinal inflammation and bacterial load are correlated in Campylobacter infections
TL;DR: The results demonstrate that molecular screening of Campylobacter spp, Salmonella spp., and Shigella spp./EIEC using the BD Max EBP assay will result in timely diagnosis and improved sensitivity.
Journal ArticleDOI
Sustained SARS-CoV-2 nucleocapsid antibody levels in nonsevere COVID-19: A population-based study
Anna Schaffner,Lorenz Risch,Myriam Weber,Sarah Thiel,Katharina Jüngert,Michael Pichler,Nadia Wohlwend,Thomas Lung,Michael Ritzler,Dorothea Hillmann,Sandra Copeland,Harald Renz,Matthias Paprotny,Martin Risch +13 more